Results 61 to 70 of about 1,899,013 (161)
TRICUSPID REGURGITATION: NO LONGER THE ‘FORGOTTEN’ VALVE
Considered initially as a bystander, tricuspid regurgitation has shown to be an important predictor of mortality in patients with left-side valvular or myocardial disease.
Livia Gheorghe +5 more
doaj
Background: Congenitally corrected transposition of the great arteries (CC-TGA) can lead to severe systemic tricuspid regurgitation (TR). There is limited evidence on transcatheter tricuspid valve replacement (TTVR) in these patients.
John T. D'Angelo, MD +7 more
doaj +1 more source
ABSTRACT Atrioventricular conduction disturbances and the need for cardiac implantable electronic device (CIED) therapy are frequently required after transcatheter tricuspid valve implantation (TTVI). The interaction between the annulus, transcatheter heart valve and the leads is often complex and the optimal management under debate.
Thomas Seiler +9 more
wiley +1 more source
State of the art: Transcatheter tricuspid valve intervention
Tricuspid regurgitation (TR) has a community prevalence of 3%, which increases with age and affects up to 7% of elderly patients. TR is secondary (functional) in 90% of cases (usually resulting from left heart disease and/or pulmonary hypertension), although atrial dilatation is an increasingly recognised cause.
Joshua Wilcox +17 more
openaire +3 more sources
Role of computed tomography in transcatheter coronary and structural heart disease interventions
Computed tomography is a noninvasive imaging technique with high spatial resolution, providing excellent definition of calcium and intravascular space through the use of contrast media.
Manuel Barreiro-Pérez +9 more
doaj +1 more source
Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili +2 more
wiley +1 more source
Background: The population of patients surviving previous multivalve surgery is expanding, and structural Heart Teams increasingly encounter complex multivalvular disease requiring reintervention, for which redo surgery carries prohibitive risk.
Cristian Mornoș +8 more
doaj +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
Tricuspid regurgitation (TR) affects over 1.6 million individuals in the United States, with a one-year mortality rate of 36.1% and a five-year survival below 30%.
Asad Gul Rao +3 more
doaj +1 more source
Patients with severe symptomatic tricuspid regurgitation were assigned to transcatheter tricuspid valve intervention. Most patients showed discontinuous renal vein blood flow (arrows, Grade IV°) prior to TTVI (baseline). At follow‐up after 1 to 3 months, patients showed continuous renal vein blood flow profile (arrows, Grade I°) representing a marked ...
Franz Josef Putz +17 more
wiley +1 more source

